|
Prescription Drug Search
Product Request Form
Vidaza is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Vidaza becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about CancerDrugsDirect.com
List of countries where we can ship Vidaza:
- Algeria
- Armenia
- Australia
- Bahrain
- Belgium
- Bolivia
- Brazil
- China
- Colombia
- Cook Islands
- Croatia
- Denmark
- Dominican Republic
- El Salvador
- Finland
- France
- Georgia
- Guadeloupe
- India
- Jordan
- Korea, Republic of
- Latvia
- Lithuania
- Moldova, Republic of
- Monaco
- Netherlands Antilles
- Norway
- Philippines
- Poland
- Romania
- Russian Federation
- Singapore
- Slovakia
- Sri Lanka
- Taiwan
- Trinidad and Tobago
- United Kingdom, UK
- United States, US
- Uruguay
- Venezuela
Latest news releases on Vidaza:
Treatment of thalassaemia - DAWN Group
However, they have not dealt with its aspects in detail. A drug called 5-azacytidine, which is sold under the trade name Vidaza, is used in the treatment of patients suffering from beta-thalassemia, a blood cell disease characterised by ...
Celgene Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report - new company profile report - Transworld News
The company has three marketed products, REVLIMID, THALOMID and VIDAZA, ABRAXANE, and ISTODAX. The company's operations are spread across more than 65 countries and regions, including Europe, Latin America, Middle East, Asia-Pacific and Canada. It operates ...
Smart Biotech Management For Clinical Trial Paths - Seekingalpha.com
In 2008, Celgene received expedited marketing approval from the European Medicines Agency (EMA) for its Vidaza drug, an injection used to treat myelodysplastic syndrome (a group of conditions where the bone marrow produces misshapen blood cells without ...
Celgene Retains Neutral Rec - Zacks.com
Apart from Revlimid, the oncology portfolio at Celgene also includes Vidaza, Abraxane, Istodax and Thalomid. Moreover, the company is investing heavily in its pipeline with multiple pipeline events lined up in the coming quarters. The most eagerly awaited ...
Celgene Retains Neutral Rec - Analyst Blog - Boston Globe
Apart from Revlimid, the oncology portfolio at Celgene also includes Vidaza, Abraxane, Istodax and Thalomid. Moreover, the company is investing heavily in its pipeline with multiple pipeline events lined up in the coming quarters. The most ...
9 Cash Laden Large Caps With Strong EPS Growth Trends - Seekingalpha.com
The company's commercial stage products include REVLIMID, an oral immunomodulatory drug for the treatment of patients with multiple myeloma and myelodysplastic syndromes (MDS); VIDAZA, a pyrimidine nucleoside analog to treat various subtypes MDS and acute ...
Zacks Reaffirms Neutral Rating on Celgene (CELG) - zolmax.com
We are also concerned about the loss of exclusivity of Vidaza in the U.S. In view of these challenges, we see limited upside potential from current levels and retain our Neutral stance on the stock. “ A number of other firms have also recently commented on CELG.
